A multicenter, real‐world study on effectiveness and safety of first‐line modified PD‐1 inhibitors with chemotherapy in advanced non‐small cell lung cancer (aNSCLC) with drive gene‐negative
Article in Cancer Medicine (February 2024)
The most recent citing publications are shown below. View all 99 publications that cite this research output on Dimensions.
Article in Cancer Medicine (February 2024)
Article in The Journal of Dermatology (February 2024)
Article in Frontiers in Immunology (February 2024)